A. Aiuti, I. J. Webb, C. Bleul, T. Springer, and J. C. Gutierrez-ramos, Progenitors to Peripheral Blood, The Journal of Experimental Medicine, vol.81, issue.1, pp.111-120, 1997.
DOI : 10.1038/382635a0

A. Peled, The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow, Journal of Clinical Investigation, vol.104, issue.9, pp.1199-1211, 1999.
DOI : 10.1172/JCI7615

A. Peled, The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice, Blood, vol.95, pp.3289-3296, 2000.

K. Imai, Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow, British Journal of Haematology, vol.97, issue.4, pp.905-916, 1999.
DOI : 10.1146/annurev.physiol.57.1.827

P. C. Trampont, CXCR4 acts as a costimulator during thymic ??-selection, Nature Immunology, vol.170, issue.2, pp.162-70, 2010.
DOI : 10.4049/jimmunol.170.1.421
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808461

K. Balabanian, Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice, Blood, vol.119, issue.24, pp.5722-5752, 2012.
DOI : 10.1182/blood-2012-01-403378

T. Sugiyama, H. Kohara, M. Noda, and T. Nagasawa, Maintenance of the Hematopoietic Stem Cell Pool by CXCL12-CXCR4 Chemokine Signaling in Bone Marrow Stromal Cell Niches, Immunity, vol.25, issue.6, pp.977-988, 2006.
DOI : 10.1016/j.immuni.2006.10.016

A. Foudi, Reduced retention of radioprotective hematopoietic cells within the bone marrow microenvironment in CXCR4-/- chimeric mice, Blood, vol.107, issue.6, pp.2243-2251, 2006.
DOI : 10.1182/blood-2005-02-0581

S. M. Devine, Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction, Blood, vol.112, issue.4, pp.990-998, 2008.
DOI : 10.1182/blood-2007-12-130179

W. C. Liles, Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist, Blood, vol.102, issue.8, pp.2728-2730, 2003.
DOI : 10.1182/blood-2003-02-0663

M. Abraham, Enhanced Unique Pattern of Hematopoietic Cell Mobilization Induced by the CXCR4 Antagonist 4F-Benzoyl-TN14003, STEM CELLS, vol.104, issue.(suppl 1), pp.2158-2166, 2007.
DOI : 10.1046/j.1365-2141.1999.01169.x

I. Petit, G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4, Nature Immunology, vol.3, issue.7, pp.687-694, 2002.
DOI : 10.1038/ni813

H. E. Broxmeyer, Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Galphai proteins and enhances engraftment of competitive, repopulating stem cells, Journal of Leukocyte Biology, vol.73, issue.5, pp.630-638, 2003.
DOI : 10.1189/jlb.1002495

J. J. Lataillade, Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival, Blood, vol.95, pp.756-768, 2000.

L. Ding and S. J. Morrison, Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches, Nature, vol.495, issue.7440, pp.231-236, 2013.
DOI : 10.1182/blood-2004-01-0272
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600153

A. Greenbaum, CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance, Nature, vol.170, issue.7440, pp.227-257, 2013.
DOI : 10.1179/014788899794813563
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600148

Y. Zhang, CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress, Scientific Reports, vol.996, issue.1, p.37827, 2016.
DOI : 10.1111/j.1749-6632.2003.tb03237.x
URL : https://hal.archives-ouvertes.fr/inserm-01472381

S. W. Lane, D. T. Scadden, and D. G. Gilliland, The leukemic stem cell niche: current concepts and therapeutic opportunities, Blood, vol.114, issue.6, pp.1150-1157, 2009.
DOI : 10.1182/blood-2009-01-202606
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723012

A. C. Spoo, M. Lubbert, W. G. Wierda, and J. A. Burger, CXCR4 is a prognostic marker in acute myelogenous leukemia, Blood, vol.109, issue.2, pp.786-791, 2007.
DOI : 10.1182/blood-2006-05-024844

E. J. Rombouts, B. Pavic, B. Lowenberg, and R. E. Ploemacher, Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia, Blood, vol.104, issue.2, pp.550-557, 2004.
DOI : 10.1182/blood-2004-02-0566

G. L. Uy, A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia, Blood, vol.119, issue.17, pp.3917-3941, 2012.
DOI : 10.1182/blood-2011-10-383406

Y. Zhang, CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model, Cell Death and Disease, vol.88, issue.10, p.396, 2012.
DOI : 10.1634/stemcells.2006-0468
URL : http://doi.org/10.1038/cddis.2012.137

B. Cho, Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy, Blood, vol.126, issue.2, pp.222-254, 2015.
DOI : 10.1182/blood-2015-02-628677

C. W. Hendrix, Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers, Antimicrobial Agents and Chemotherapy, vol.44, issue.6, pp.1667-1673, 2000.
DOI : 10.1128/AAC.44.6.1667-1673.2000

X. Jiang, Advances in the assessment and control of the effector functions of therapeutic antibodies, Nature Reviews Drug Discovery, vol.45, issue.2, pp.101-111, 2011.
DOI : 10.1016/j.cyto.2008.11.008

W. Wang, A. K. Erbe, J. A. Hank, Z. S. Morris, and P. M. Sondel, NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy, Frontiers in Immunology, vol.6, 2015.
DOI : 10.3389/fimmu.2015.00368
URL : http://doi.org/10.3389/fimmu.2015.00368

A. M. Scott, J. P. Allison, and J. Wolchok, Monoclonal antibodies in cancer therapy, Cancer Immun, vol.12, p.14, 2012.

R. Crazzolara, High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia, British Journal of Haematology, vol.58, issue.3, pp.545-553, 2001.
DOI : 10.1038/31269

I. Kato, Identification of Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1/CXCR4 Axis, PLoS ONE, vol.105, issue.11, 27042.
DOI : 10.1371/journal.pone.0027042.s007

K. Schepers, T. B. Campbell, and E. Passegue, Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities, Cell Stem Cell, vol.16, issue.3, pp.254-267, 2015.
DOI : 10.1016/j.stem.2015.02.014
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391962

D. Bonnet and J. Dick, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nature Medicine, vol.6, issue.7, pp.730-737, 1997.
DOI : 10.1128/MCB.6.9.3156

W. Chan and B. J. Huntly, Leukemia Stem Cells in Acute Myeloid Leukemia, Seminars in Oncology, vol.35, issue.4, pp.326-361, 2008.
DOI : 10.1053/j.seminoncol.2008.04.003

A. Krause, M. Luciana, F. Krause, and E. M. Rego, Targeting the Acute Myeloid Leukemia Stem Cells, Anti-Cancer Agents in Medicinal Chemistry, vol.10, issue.2, pp.104-114, 2010.
DOI : 10.2174/187152010790909281

Y. Zhang, Hematopoietic Progenitor Cells, Stem Cells, vol.276, issue.6, pp.1015-1029, 2004.
DOI : 10.4049/jimmunol.169.12.7000

D. C. Taussig, Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells, Blood, vol.112, issue.3, pp.568-575, 2008.
DOI : 10.1182/blood-2007-10-118331